BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo K, Feng Y, Zheng X, Sun L, Wasan HS, Ruan S, Shen M. Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors. Front Oncol 2021;11:644134. [PMID: 33937049 DOI: 10.3389/fonc.2021.644134] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
Number Citing Articles
1 Ceramella J, Chimento A, Iacopetta D, De Luca A, Coronel Vargas G, Rosano C, Pezzi V, Saturnino C, Sinicropi MS. A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer. Applied Sciences 2022;12:6531. [DOI: 10.3390/app12136531] [Reference Citation Analysis]
2 Ge H, Xu C, Chen H, Liu L, Zhang L, Wu C, Lu Y, Yao Q. Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms. Front Pharmacol 2022;13:842295. [DOI: 10.3389/fphar.2022.842295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Feng C, Liu S, Shang Z. Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes. Front Cell Dev Biol 2022;9:798898. [DOI: 10.3389/fcell.2021.798898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Segovia-Mendoza M, García-Quiroz J, Díaz L, García-Becerra R. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update. Int J Mol Sci 2021;22:12741. [PMID: 34884550 DOI: 10.3390/ijms222312741] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
5 Leischner C, Burkard M, Michel A, Berchtold S, Niessner H, Marongiu L, Busch C, Frank J, Lauer UM, Venturelli S. Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status. Molecules 2021;26:5586. [PMID: 34577057 DOI: 10.3390/molecules26185586] [Reference Citation Analysis]